For beneficiaries to be eligible under the BALANCE Model, providers must attest that they meet certain clinical criteria, including qualifying for a GLP-1 for a currently covered use (such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea) or for use to treat obesity based on similar clinical criteria as applied in the Medicare GLP-1 Bridge (Figure 3)
self-funded plans can exclude
How GLP-1 Agonists Work Appetite Regulation : By mimicking GLP-1, these medications help decrease appetite and increase feelings of satiety, making it easier to consume fewer calories
NoDoz) must include [a series of] warnings, write the Johns Hopkins researchers, whereas a 500 mg energy drink can be marketed with no such warnings and no information on caffeine dose amount in the product. As early as 2009, sports and medical organizations began issuing position statements discouraging energy-drink consumption by young people
Expert Care : Our professional staff is highly trained to ensure you receive the best possible treatment